Company: IMNN
Filing Date: 2025-12-31
Form Type: 424B5
Source: 0001493152-25-029712
Chunk: 1

Company: Imunon, Inc.
Filing Date: 2025-12-31
Form: 424B5
Chunk 1
---
 and we do not expect a market to develop. In addition, we do not intend to list the Pre-funded Warrants or the Warrants, nor do we expect the Pre-funded Warrants or the Warrants to be quoted, on the Nasdaq Capital Market or on any other national securities exchange or any other nationally recognized trading system. Without an active trading market, the liquidity of the Pre-funded Warrants and the Warrants will be limited.

|                                 |     | PER SHARE AND ACCOMPANYING WARRANT |        |     | PER PRE-FUNDED WARRANT AND ACCOMPANYING WARRANT |        |     | TOTAL |              |
|:--------------------------------|:----|:-----------------------------------|-------:|:----|:------------------------------------------------|-------:|:----|:------|-------------:|
| Offering price                  |     | $                                  | 3.6100 |     | $                                               | 3.6099 |     | $     | 7,000,040.63 |
| Placement Agents’ fees(1)       |     | $                                  | 0.2527 |     | $                                               | 0.2527 |     | $     |   490,014.11 |
| Proceeds to us, before expenses |     | $                                  | 3.3573 |     | $                                               | 3.3572 |     | $     | 6,510,026.52 |

| (1) | Represents                                                                                                                             
 a cash fee equal to 7.0% of the aggregate gross proceeds raised in the offering. We have also agreed to reimburse the Placement Agents 
 for certain expenses in connection with this offering. See “Plan of Distribution” beginning on page S-13 for additional                
 information for a description of the compensation payable to the Placement Agents.                                                     |

We have engaged Maxim Group LLC, as lead placement agent,and Brookline Capital Markets, a division of Arcadia Securities, LLC, as co-placement agent (collectively, the “Placement Agents”), to act as our placement agents in connection with this offering. The Placement Agents are not purchasing or selling any of the securities offered pursuant to this prospectus supplement and the accompanying prospectus.

Investing in our securities involves a high degree of risk. Before making an investment decision, please read “Risk Factors” beginning on page S-3 of this prospectus supplement and in the documents incorporated by reference herein.

Neither the Securities and Exchange Commission nor any state securities commission has approved or disapproved of these securities or determined if this